246 related articles for article (PubMed ID: 28400772)
1. Sphingolipids Are Dual Specific Drug Targets for the Management of Pulmonary Infections: Perspective.
Sharma L; Prakash H
Front Immunol; 2017; 8():378. PubMed ID: 28400772
[TBL] [Abstract][Full Text] [Related]
2. Sphingolipids in Lung Pathology in the Coronavirus Disease Era: A Review of Sphingolipid Involvement in the Pathogenesis of Lung Damage.
Khan SA; Goliwas KF; Deshane JS
Front Physiol; 2021; 12():760638. PubMed ID: 34690821
[TBL] [Abstract][Full Text] [Related]
3. Sphingolipids in cardiovascular and cerebrovascular systems: Pathological implications and potential therapeutic targets.
Kawabori M; Kacimi R; Karliner JS; Yenari MA
World J Cardiol; 2013 Apr; 5(4):75-86. PubMed ID: 23675553
[TBL] [Abstract][Full Text] [Related]
4. The role of sphingosine 1-phosphate metabolism in bone and joint pathologies and ectopic calcification.
El Jamal A; Bougault C; Mebarek S; Magne D; Cuvillier O; Brizuela L
Bone; 2020 Jan; 130():115087. PubMed ID: 31648078
[TBL] [Abstract][Full Text] [Related]
5. Role of sphingosine kinase localization in sphingolipid signaling.
Wattenberg BW
World J Biol Chem; 2010 Dec; 1(12):362-8. PubMed ID: 21537471
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
Selvam SP; Ogretmen B
Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of sphingolipid metabolic enzymes leads to high levels of sphingosine-1-phosphate and ceramide in human hepatocellular carcinoma.
Miura K; Nagahashi M; Prasoon P; Hirose Y; Kobayashi T; Sakata J; Abe M; Sakimura K; Matsuda Y; Butash AL; Katsuta E; Takabe K; Wakai T
Hepatol Res; 2021 May; 51(5):614-626. PubMed ID: 33586816
[TBL] [Abstract][Full Text] [Related]
8. The role of sphingolipids in respiratory disease.
Yang Y; Uhlig S
Ther Adv Respir Dis; 2011 Oct; 5(5):325-44. PubMed ID: 21900155
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
[TBL] [Abstract][Full Text] [Related]
10. Sphingolipids in the lungs.
Uhlig S; Gulbins E
Am J Respir Crit Care Med; 2008 Dec; 178(11):1100-14. PubMed ID: 18755926
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine 1-phosphate is a key metabolite linking sphingolipids to glycerophospholipids.
Kihara A
Biochim Biophys Acta; 2014 May; 1841(5):766-72. PubMed ID: 23994042
[TBL] [Abstract][Full Text] [Related]
12. De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells.
Berdyshev EV; Gorshkova IA; Usatyuk P; Zhao Y; Saatian B; Hubbard W; Natarajan V
Cell Signal; 2006 Oct; 18(10):1779-92. PubMed ID: 16529909
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy.
Gupta P; Taiyab A; Hussain A; Alajmi MF; Islam A; Hassan MI
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33920887
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases.
Hait NC; Oskeritzian CA; Paugh SW; Milstien S; Spiegel S
Biochim Biophys Acta; 2006 Dec; 1758(12):2016-26. PubMed ID: 16996023
[TBL] [Abstract][Full Text] [Related]
15. Bioactive Sphingolipids as Major Regulators of Coronary Artery Disease.
Song JH; Kim GT; Park KH; Park WJ; Park TS
Biomol Ther (Seoul); 2021 Jul; 29(4):373-383. PubMed ID: 33903284
[TBL] [Abstract][Full Text] [Related]
16. Sphingolipids and the balancing of immune cell function: lessons from the mast cell.
Olivera A; Rivera J
J Immunol; 2005 Feb; 174(3):1153-8. PubMed ID: 15661867
[TBL] [Abstract][Full Text] [Related]
17. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
Gatt S; Dagan A
Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
[TBL] [Abstract][Full Text] [Related]
18. The sphingolipid rheostat: a potential target for improving pancreatic islet survival and function.
Jessup CF; Bonder CS; Pitson SM; Coates PT
Endocr Metab Immune Disord Drug Targets; 2011 Dec; 11(4):262-72. PubMed ID: 21696364
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine Kinase Inhibitors as Maintenance Therapy of Glioblastoma After Ceramide-Induced Response.
Sordillo LA; Sordillo PP; Helson L
Anticancer Res; 2016 May; 36(5):2085-95. PubMed ID: 27127108
[TBL] [Abstract][Full Text] [Related]
20. The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death.
Van Brocklyn JR; Williams JB
Comp Biochem Physiol B Biochem Mol Biol; 2012 Sep; 163(1):26-36. PubMed ID: 22613819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
